150 related articles for article (PubMed ID: 31797364)
1. Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab.
Uzunov M; Demeret S; Nguyen-Quoc S; Morel V; Bellanger A; Chavez H; Gasnault J; Leblond V; Roos-Weil D
Br J Haematol; 2020 Mar; 188(6):e82-e84. PubMed ID: 31797364
[No Abstract] [Full Text] [Related]
2. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy.
Venniyoor A
Saudi J Kidney Dis Transpl; 2019; 30(4):998-999. PubMed ID: 31464264
[No Abstract] [Full Text] [Related]
4. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
5. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
[TBL] [Abstract][Full Text] [Related]
6. Novel treatments for progressive multifocal leukoencephalopathy.
Bennett KM; Fernandes PM
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
[TBL] [Abstract][Full Text] [Related]
7. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
[No Abstract] [Full Text] [Related]
8. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
[No Abstract] [Full Text] [Related]
9. Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer.
Komatsu T; Nakamura K; Kawase A
J Thorac Oncol; 2017 Sep; 12(9):e143-e144. PubMed ID: 28838715
[No Abstract] [Full Text] [Related]
10. Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy.
Panariello L; Fattore D; Annunziata MC; Piantedosi F; Gilli M; Fabbrocini G
Eur J Cancer; 2018 Nov; 103():284-286. PubMed ID: 30268391
[No Abstract] [Full Text] [Related]
11. Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantation.
Lam W; Al-Shaibani Z; Kumar D; Viswabandya A; Thyagu S; Michelis FV; Kim DD; Lipton JH; Messner HA; Deotare U
Antivir Ther; 2017; 22(8):721-725. PubMed ID: 28362268
[TBL] [Abstract][Full Text] [Related]
12. Durable Long-Term Response in a Patient With Diffuse Large B-Cell Lymphoma Treated With Nivolumab.
Ginnaram SR; Mason EF; Reddy NM
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e934-e936. PubMed ID: 32778514
[No Abstract] [Full Text] [Related]
13. Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for acute myeloid leukemia.
Lee HC; Mulanovich V; Nieto Y
J Natl Compr Canc Netw; 2014 Dec; 12(12):1660-4; quiz 1664. PubMed ID: 25505206
[TBL] [Abstract][Full Text] [Related]
14. Complete Response of Primary Refractory ALK-Positive Large B-Cell Lymphoma Treated With Single-Agent Nivolumab.
Sandoval-Sus JD; Brahim A; Khan A; Deutsch Y; Raphael B; Ansari-Lari A; Fernandez HF; Raez LE
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):e113-e117. PubMed ID: 32033930
[No Abstract] [Full Text] [Related]
15. A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab.
Khunger M; Velcheti V
J Thorac Oncol; 2017 Jul; 12(7):e96-e97. PubMed ID: 28629548
[No Abstract] [Full Text] [Related]
16. Brain Lesion in the Setting of Chronic Rituximab Treatment.
Yazdani M; Antonucci M; Spampinato MV
JAMA Oncol; 2020 Jul; 6(7):1093-1094. PubMed ID: 32463440
[No Abstract] [Full Text] [Related]
17. Development of Resistant GvHD in a Patient Treated with Nivolumab for Hodgkins Lymphoma Relapse after Allogeneic Unrelated Transplantation.
Steinerová K; Jindra P; Lysák D; Karas M
Klin Onkol; 2019; 32(1):66-69. PubMed ID: 30764632
[TBL] [Abstract][Full Text] [Related]
18. Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Treated with Nivolumab.
Funazo T; Nomizo T; Kim YH
J Thorac Oncol; 2017 Sep; 12(9):e140-e141. PubMed ID: 28838713
[No Abstract] [Full Text] [Related]
19. Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis.
Ide M; Tanaka K; Sunami S; Asoh T; Maeyama T; Tsuruta N; Nakanishi Y; Okamoto I
Thorac Cancer; 2018 Nov; 9(11):1519-1521. PubMed ID: 30152594
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy in a lung transplant recipient.
Shitrit D; Nirit L; Shiran SI; Izbicki G; Sofer D; Eldad M; Kramer MR
J Heart Lung Transplant; 2003 Aug; 22(8):946-50. PubMed ID: 12909477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
